Control Yuan member Yeh Yao-peng (葉耀鵬) yesterday said he will proceed with his probe into the case of Yu Chang Biologics Co, even though prosecutors announced this week that they have decided to close the case involving former Democratic Progressive Party (DPP) chairperson Tsai Ing-wen (蔡英文) as no criminal wrong-doing was uncovered.
Yeh said he will go ahead with his plan as scheduled to subpoena individuals involved in the case, including Tsai and DPP Chairman Su Tseng-chang (蘇貞昌).
Yu Chang is now called TaiMed Biologics Inc.
On Tuesday, the Supreme Prosecutors’ Office Special Investigation Division (SID) closed its investigation into the case and cleared Tsai of any wrongdoing.
In late November last year, ahead of the Jan. 14 presidential election, Tsai, then the DPP’s presidential candidate, was accused by the Chinese Nationalist Party (KMT) of manipulating investments by the National Development Fund (NDF) in TaiMed when she was vice premier in 2007. Su was premier at the time.
Yeh said it remains necessary to clarify if there had been any administrative irregularities.
The Control Yuan identified issues to be cleared up, including whether the use of the NDF for Yu Chang was in accordance with statutory procedures and whether Tsai abided by the conflict-of-interest policies set forth in the Civil Servants Work Act (公務員服務法) in her dealings with the case.
KMT Legislator Lo Shu-lei (羅淑蕾) said she did not consider that a probe by the Control Yuan into the case necessary because “judicial review had brought it to an end.”
DPP Legislator Tsai Huang-liang (蔡煌瑯) said the moves were driven by political motives.
“The SID has proved that Tsai was innocent and now the Control Yuan and the KMT want to drag Chairman Su down,” Tsai said.